View as an RSS Feed
View IPOdesktop's Articles BY TICKER:
AAOI, AAVL, ABDC, ABHB, ABY, ACRE, ACTV, ADHD, ADMS, ADNC, ADPT, ADSI, AERI, AGMX, AGRX, AGTC, AHH, AKAO, AKBA, AL, ALDR, ALDW, ALDX, ALLY, ALSN, AMBA, AMBR, AMBX, AMC, AMDA, AMH, AMID, AMPH, AMRE, AMTG, ANET, ANFI, ANGI, APAM, APO, AQ, AQXP, AR, ARBR, ARCO, ARCX, ARDX, ARES, ARGS, ARMK, ARPI, ARS, ASC, ASPN, ATEN, ATHL, ATHM, ATRA, AURX, AVG, AVIV, AWAY, BATS, BCC, BCEI, BCOV, BCRH, BERY, BFAM, BIND, BIOA, BLMN, BLOX, BLUE, BNFT, BNK, BNNY, BRDR, BRG, BRSE, BRSS, BRX, BSTM, BURL, BV, CAHS, CAPN, CARA, CARB, CARH, CBF, CBIO, CBSO, CCCR, CCFG, CCS, CCXI, CDNA, CELP, CEMP, CERE, CERU, CFRX, CG, CGIX, CHEF, CHGG, CHKR, CHUY, CIO, CJES, CK, CLDN, CLVS, CMCM, CMFN, CMLP, CNCE, CNOB, COMM, CONE, CORI, COTY, COUP, COVS, CQH, CRCM, CRSR, CRTO, CSLT, CSOD, CSTE, CSTM, CTLT, CTRL, CTT, CUDA, CVRR, CVT, CYNI, CZR, DATA, DATE, DCIN, DDMGQ, DFRG, DKL, DLNG, DLPH, DMD, DNKN, DOC, DOR, DPRX, DRII, DRNA, DRTX, DSG, DSKY, DWRE, EAC, EARN, EARS, EBIO, ECOM, ECR, EDG, EGRX, EIGI, ELLI, ELOQ, EMES, ENBL, ENPH, ENTA, ENVI, ENXP, EOPN, EPAM, EPE, EPZM, EQM, ESNT, ESRT, ET, EVDY, EVER, EVHC, EVOK, EXA, FATE, FB, FCB, FELP, FENG, FET, FEYE, FFNT, FFWM, FGL, FI, FIO, FIVE, FIVN, FLTX, FLXN, FMI, FNDR, FOXF, FPI, FPRX, FRAC, FRAN, FRSH, FSL, FSTM, FUEL, FX, FXCM, GARS, GBIM, GCAP, GCTS, GDCT, GFIS, GIMO, GLMD, GLOB, GLOG, GLOP, GLYC, GMED, GNBC, GOGO, GOMO, GPRO, GRPN, GRUB, GSE, GSJK, GWAY, GWGH, GWRE, HASI, HAWK, HCLP, HDS, HELI, HIIQ, HIVE, HLSS, HLT, HMHC, HMLP, HMST, HPTX, HQY, HRTG, HZNP, I, IBP, IBTX, ICC, ICD, ICPT, IMDZ, IMI, IMPR, IMPV, IMS, INGN, INNL, INSY, INVN, IPDN, IRT, JD, JGW, JIVE, JMEI, JMI, KANG, KBIO, KIN, KING, KIOR, KITE, KMI, KNMD, KORS, KOS, KPTI, KTWO, KYAK, KYTH, LADR, LAEC, LAND, LDRH, LEAF, LEJU, LGIH, LGP, LITB, LLGX, LMNS, LNKD, LNTH, LOCK, LOCO, LOXO, LPDX, LPI, LPRI, LQ, LRE, LUCA, LXFR, MACK, MAPI, MBII, MBLY, MBUU, MC, MCEP, MCLB, MCUR, MDWD, MEMP, MEP, MFRM, MGNX, MIK, MITT, MKTG, MKTO, MM, MMI, MN, MOBL, MODL, MODN, MONT, MPLX, MPO, MRC, MRCC, MRD, MRIN, MRKT, MRNS, MSBI, MTBC, MTDR, MTGE, MTLS, MTSI, MVNR, MYCC, NBCB, NBHC, NCFT, NCLH, NDLS, NDRO, NEP, NERV, NGL, NGVC, NLNK, NMBL, NMFC, NMIH, NORD, NOW, NQ, NRE, NRKM, NRX, NSE, NSLP, NSM, NTI, NVGS, NWHM, NYLD, OAK, OAKS, OCIR, OCUL, OEC, OFS, OILT, OMED, OPB, OPHT, OPWR, ORC, ORPN, OTIC, OXFD, P, PAGP, PAHC, PANW, PARN, PAYC, PBF, PBFX, PCTY, PDH, PE, PEAK, PEER, PEGI, PER, PETX, PF, PFMT, PFNX, PFPT, PFSI, PGEM, PIH, PINC, PMCA, PRLB, PRSS, PSMI, PSXP, PTLA, Q, QEPM, QGOG, QIHU, QIWI, QLYS, QRE, QTNT, QTS, QTWO, QUNR, RARE, RATE, RCAP, RCPT, RDUS, REGI, RENN, REPH, REXR, RGDO, RGLS, RH, RIBX, RICE, RIGP, RKUS, RLGY, RLJ, RLYP, RM, RMAX, RNA, RNDY, RNF, RNG, ROYT, RPAI, RPXC, RRMS, RSPP, RTGN, RUBI, RVNC, RXN, RYI, SABR, SAGE, SALE, SAMG, SAVE, SBUX, SBY, SC, SCAI, SCM, SCRT, SCTY, SCYX, SDLP, SDR, SEAS, SEMI, SERV, SFBS, SFM, SFXE, SGLX, SGM, SGNL, SGNT, SIR, SIRI, SKUL, SLCA, SMLP, SMLR, SMSMY, SMTH, SN, SNDX, SNOW, SNS, SPKE, SPLK, SPPP, SPWH, SQBK, SQNS, SRC, SRLP, SRVA, SSNI, SSTK, STAY, STCK, STIR, STML, STST, SUNS, SUPN, SUSP, SXC, SXCP, SXE, SYF, SYNC, SZYM, TAG, TAM, TAOM, TBRA, TCPI, TCS, TEDU, TEP, TERP, THNX, THR, TLMR, TLOG, TLYS, TMG, TMS, TMWE, TNDM, TNET, TNGO, TOUR, TOYS, TPH, TPRE, TPVG, TRIV, TRLA, TRMR, TRUE, TRUP, TRVN, TSC, TSE, TSLX, TSQ, TSRO, TTOO, TTPH, TUBE, TUDO, TUMI, TWAV, TWOU, TWTR, TXTR, UAGR, UAN, UBNT, UCP, USAC, VBLX, VCRA, VCYT, VEBM, VEEV, VHS, VIPS, VJET, VLP, VLRS, VMEM, VNCE, VNET, VNOM, VNTV, VOC, VOYA, VRNS, VSAR, VSTM, VTL, VTTI, WAGE, WAIR, WB, WBAI, WGH, WGP, WHF, WHSM, WHZ, WIFI, WIX, WLKP, WMC, WMS, WNRL, WPT, WSTC, WUBA, WWAV, XENT, XLRN, XNCR, XNET, XON, XONE, XOOM, YELP, YNDX, YUME, YY, Z, ZEN, ZFC, ZFGN, ZLTQ, ZNGA, ZOES, ZPIN, ZSAN, ZSPH, ZTS, ZU, ZX
IPO Preview: Achaogen
- Achaogen is a clinical-stage biopharmaceutical company.
- The lead product is funded with a contract from the Biomedical Advanced Research and Development Authority for up to $103.8 million.
- AKAO initiated a Phase 3 superiority trial of plazomicin in the first quarter of 2014.
IPO Preview: Coupons.com
- Provides digital coupons.
- For Q4 2013 coup's P/E is less than Retailmenot's (SALE).
- SALE is up 73% since December 9, 2013.
IPO Preview: Recro Pharma
- Clinical stage specialty pharmaceutical company.
- No collaboration partners.
- Lead candidate has only completed Phase 1b clinical trials.
IPO Preview: Aquinox Pharmaceuticals
- Clinical-stage pharmaceutical company.
- Shareholders indicated an interest in buying up to $15 million on the IPO.
- Pre-IPO J&J Dev owns 24%, Pfizer owns 16.5%.
IPO Preview: TriplePoint Venture Growth BDC
- TPVG is a newly-formed business development corporation.
- TPVG plans on paying 8.5% with warrant kickers from high-tech companies.
- Probably a good investment for patient investors for the income portion of their portfolio.
- IPO Preview: Varonis Systems
- IPO Preview: Lumenis
- IPO Preview: Inogen
- IPO Preview: Semler Scientific
- IPO Preview: Concert Pharmaceuticals
- IPO Preview: Installed Building Products
- IPO Preview: Amedica
- IPO Preview: Eagle Pharmaceuticals
- IPO Preview: Talmer Bancorp
- IPO Preview: Flexion Therapeutics
- IPO Preview: Argos Therapeutics
- IPO Preview: NephroGenex
- IPO Preview: CM Finance
- IPO Preview: Ladder Capital
- IPO Preview: Revance Therapeutics
- IPO Preview: Eleven Biotherapeutics
- IPO Preview: Malibu Boats
- IPO Preview: The New Home Company
- IPO Preview: Ultragenyx Pharmaceutical
- IPO Preview: Cara Therapeutics
- IPO Preview: Intrawest Resort Holdings
- IPO Preview: Dicerna Pharmaceuticals
- IPO Preview: Care.com
- IPO Preview: Rice Energy
- IPO Preview: Santander Consumer USA Holdings
- IPO Preview: EP Energy
- IPO Preview: CHC Group